Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
65,34
USD
|
+0,83%
|
|
-3,27%
|
-21,74%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
627,7
|
1.471
|
3.823
|
4.336
|
8.186
|
6.846
|
-
|
-
|
Bedrijfswaarde
1 |
531,8
|
1.142
|
3.495
|
4.163
|
8.179
|
6.570
|
6.240
|
6.375
|
K/w-verhouding
|
-5,03
x
|
-10,5
x
|
-16,3
x
|
-10,6
x
|
-15,3
x
|
-14,8
x
|
-20,5
x
|
-64,8
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
23,4
x
|
26,3
x
|
54,3
x
|
45,8
x
|
1.087
x
|
565
x
|
41,5
x
|
13,4
x
|
Bedrijfswaarde/omzet
|
19,8
x
|
20,5
x
|
49,6
x
|
44
x
|
1.086
x
|
543
x
|
37,8
x
|
12,4
x
|
Bedrijfswaarde/EBITDA
|
-5,45
x
|
-12,4
x
|
-19
x
|
-13,1
x
|
-16,9
x
|
-15,8
x
|
-24
x
|
-149
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-18,3
x
|
-13,4
x
|
-19,7
x
|
-14,6
x
|
-16
x
|
-27,1
x
|
FCF Yield
|
-
|
-
|
-5,48%
|
-7,47%
|
-5,08%
|
-6,87%
|
-6,25%
|
-3,7%
|
Price to Book
|
-57,4
x
|
13
x
|
15,8
x
|
-40,3
x
|
-22
x
|
-12,2
x
|
-48,7
x
|
-16,6
x
|
Aantal aandelen (in duizenden)
|
59.161
|
70.779
|
83.883
|
94.631
|
98.054
|
104.774
|
-
|
-
|
Referentieprijs
2 |
10,61
|
20,78
|
45,58
|
45,82
|
83,49
|
65,34
|
65,34
|
65,34
|
Datum van publicatie
|
3/03/20
|
25/02/21
|
24/02/22
|
1/03/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
26,87
|
55,83
|
70,43
|
94,59
|
7,53
|
12,11
|
165
|
512,2
|
EBITDA
1 |
-97,57
|
-92,11
|
-184
|
-318,4
|
-484,3
|
-416,6
|
-260,2
|
-42,85
|
Bedrijfsresultaat (EBIT)
1 |
-98,87
|
-93,94
|
-186,3
|
-324,2
|
-496,2
|
-448
|
-339,7
|
-114,7
|
Operationele Marge
|
-367,97%
|
-168,27%
|
-264,54%
|
-342,75%
|
-6.589,71%
|
-3.699,61%
|
-205,81%
|
-22,4%
|
Resultaat voor belastingen (EBT)
1 |
-121,7
|
-127,3
|
-215,3
|
-389
|
-526,2
|
-469,9
|
-360,4
|
-150,8
|
Nettowinst (verlies)
1 |
-121,7
|
-127,3
|
-215,3
|
-389
|
-526,2
|
-465,6
|
-353
|
-134,2
|
Nettomarge
|
-452,93%
|
-228%
|
-305,72%
|
-411,21%
|
-6.988,63%
|
-3.845,09%
|
-213,91%
|
-26,2%
|
WPA
2 |
-2,110
|
-1,970
|
-2,800
|
-4,330
|
-5,450
|
-4,414
|
-3,180
|
-1,008
|
Free Cash Flow
1 |
-
|
-
|
-191,4
|
-310,9
|
-415,7
|
-451,2
|
-389,8
|
-235,6
|
FCF-marge
|
-
|
-
|
-271,76%
|
-328,64%
|
-5.521,24%
|
-3.726,84%
|
-236,21%
|
-46,01%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/03/20
|
25/02/21
|
24/02/22
|
1/03/23
|
27/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
7,42
|
5,437
|
55,6
|
1,148
|
88,97
|
2,515
|
1,957
|
4,613
|
0,867
|
0,378
|
1,672
|
0,9066
|
0,8853
|
4,421
|
0,9213
|
-
|
EBITDA
|
-
|
-68,74
|
-20,97
|
-76,52
|
-9,467
|
-107
|
-125,4
|
-122,6
|
-120,2
|
-120,4
|
-121,1
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-62,72
|
-69,2
|
-21,7
|
-77,86
|
-10,87
|
-108,4
|
-127
|
-124,5
|
-122
|
-122,3
|
-127,4
|
-115,6
|
-112,8
|
-106,9
|
-111,9
|
-122
|
Operationele Marge
|
-845,28%
|
-1.272,78%
|
-39,04%
|
-6.781,97%
|
-12,22%
|
-4.311,77%
|
-6.491,06%
|
-2.698,31%
|
-14.077,16%
|
-32.345,24%
|
-7.620,69%
|
-12.753,22%
|
-12.745,99%
|
-2.416,96%
|
-12.140,89%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-80,19
|
-76,09
|
-30,57
|
-89,44
|
-19,82
|
-142,3
|
-137,4
|
-131,3
|
-128,6
|
-129,4
|
-136,9
|
-122,3
|
-120,4
|
-113,9
|
-119,3
|
-122
|
Nettowinst (verlies)
1 |
-80,19
|
-76,09
|
-30,57
|
-89,44
|
-19,82
|
-142,3
|
-137,4
|
-131,3
|
-128,6
|
-129,4
|
-136,9
|
-119,3
|
-118,2
|
-113,8
|
-119,9
|
-122
|
Nettomarge
|
-1.080,73%
|
-1.399,41%
|
-54,98%
|
-7.791,38%
|
-22,28%
|
-5.658,45%
|
-7.019,93%
|
-2.846,07%
|
-14.837,02%
|
-34.238,62%
|
-8.187,56%
|
-13.157,74%
|
-13.351,43%
|
-2.574,12%
|
-13.018,59%
|
-
|
WPA
2 |
-
|
-0,9500
|
-0,3600
|
-1,050
|
-0,2300
|
-1,520
|
-1,450
|
-1,380
|
-1,340
|
-1,350
|
-1,380
|
-1,149
|
-1,124
|
-1,081
|
-1,081
|
-1,200
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
6/08/20
|
3/11/21
|
24/02/22
|
4/05/22
|
4/08/22
|
3/11/22
|
1/03/23
|
4/05/23
|
3/08/23
|
2/11/23
|
27/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
95,9
|
328
|
329
|
173
|
7,45
|
276
|
606
|
471
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-191
|
-311
|
-416
|
-451
|
-390
|
-236
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-112%
|
-121%
|
-572%
|
-
|
-92,7%
|
-31,3%
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-31,3%
|
-41,9%
|
-57,2%
|
-80,7%
|
-86,9%
|
-46,6%
|
Totale activa
1 |
-
|
-
|
687,6
|
928
|
919,5
|
576,6
|
406,4
|
288,1
|
Nettoactief per aandeel
2 |
-0,1800
|
1,600
|
2,880
|
-1,140
|
-3,800
|
-5,350
|
-1,340
|
-3,930
|
Cashflow per aandeel
2 |
-
|
-
|
-
|
-3,330
|
-4,290
|
-2,940
|
-1,520
|
-
|
Capex
1 |
-
|
-
|
48,9
|
11,3
|
1,42
|
6,8
|
24,5
|
48,2
|
Capex/omzet
|
-
|
-
|
69,39%
|
11,98%
|
18,8%
|
56,13%
|
14,86%
|
9,41%
|
Datum van publicatie
|
3/03/20
|
25/02/21
|
24/02/22
|
1/03/23
|
27/02/24
|
-
|
-
|
-
|
Laatste slotkoers
65,34
USD Gemiddelde koersdoel
91,34
USD Spread / Gemiddelde doel +39,79% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -21,74% | 6,85 mld. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,74 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|